Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial

High-Flow Nasal Oxygen vs Noninvasive Positive Airway Pressure in Hypoxemic Patients After Cardiothoracic Surgery

(2015) François Stéphan et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure

(2015) Jean-Pierre Frat et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pressures Delivered By Nasal High Flow Oxygen During All Phases of the Respiratory Cycle

(2013) R. L. Parke et al.   Respiratory Care

Effects of Nasal High Flow on Ventilation in Volunteers, COPD and Idiopathic Pulmonary Fibrosis Patients

(2012) Jens Bräunlich et al.   RESPIRATION

Oxygen delivery through high-flow nasal cannulae increase end-expiratory lung volume and reduce respiratory rate in post-cardiac surgical patients

(2011) A. Corley et al.   BRITISH JOURNAL OF ANAESTHESIA

The clinical utility of long-term humidification therapy in chronic airway disease

(2010) Harold Rea et al.   RESPIRATORY MEDICINE

Research in high flow therapy: Mechanisms of action

(2009) Kevin Dysart et al.   RESPIRATORY MEDICINE